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 ABSTRACT 
 Parturition is a necessary event for production in 
dairy cattle, and assistance at calving is common. 
There is limited use of nonsteroidal antiinflammatory 
drugs for the alleviation of calving pain and a paucity 
of research on the effects of these drugs on postpartum 
health and performance. This randomized triple blind 
clinical trial involved Holstein cows (n = 42) and heif-
ers (n = 61) that experienced an assisted parturition. 
These animals received either 1 injection of meloxicam 
(0.5 mg/kg of body weight) or placebo subcutaneously 
24 h following calving. Outcome measures included dry 
matter intake (DMI) and milk production for the first 
14 d in milk, blood metabolites sampled over 12 d, 
health events for the first 60 d in milk, as well as lying 
and feeding behavior 24 h following injection. Continu-
ous data were analyzed using multivariable regression 
models. Binary outcomes were analyzed using a mixed 
logistic model with cow modeled using a random inter-
cept. This study failed to show any significant effects of 
treatment on DMI, milk production, blood metabolites, 
or health events. A possible explanation for the lack 
of treatment differences could be that the meloxicam 
was administered too late after calving. Meloxicam 
increased feeding time as well as bunk visit frequency 
in the 24 h following injection. Regardless of treatment, 
animals that had retained fetal membranes produced 
less milk and had higher serum haptoglobin concen-
trations. Future research is warranted to examine the 
effects of antiinflammatory drugs administered closer 
to the time of calving on health and production. 
 Key words:   nonsteroidal antiinflammatory drug ,  dys-
tocia ,  pain ,  welfare 
 INTRODUCTION 
 Parturition is necessary for dairy production and as-
sisted calving is common. Calving is a painful event that 
leads to inflammation (Bionaz et al., 2007). Dystocia 
rates are higher in North America (>10%) compared 
with other parts of the world (<5%), and, regardless of 
country, are much higher in primiparous animals (Mee, 
2008). Severe dystocia (i.e., cases requiring either heavy 
tractive force with a calf puller, extensive corrections of 
malpositions, or caesarean section) was associated with 
reduced viability of the calf and reduced fertility and 
survival of the dam (Tenhagen et al., 2007). Dystocia 
negatively affected early lactation performance in Hol-
stein cows, with peak yield lowered by 0.39, 2.2, 2.2, and 
2.5 kg for cows in parities 1 to 4, respectively (Atashi et 
al., 2012). Dystocia is a risk factor for metritis and for 
purulent vaginal discharge (Dubuc et al., 2010). 
 In a questionnaire to cattle veterinarians in the United 
Kingdom, the median estimate of pain of dystocia was 
7 out of 10 (Huxley and Whay, 2006). Sixty-six percent 
of respondents indicated using a nonsteroidal antiin-
flammatory drug (NSAID) in some cases of dystocia 
(Huxley and Whay, 2006). In a survey on analgesic use 
among Canadian veterinarians in 2004–2005, the mean 
estimate of pain level was 5.3 out of 10 (Hewson et 
al., 2007). Thirty-four percent of veterinarians provided 
analgesia to some or all cases of dystocia (Hewson et 
al., 2007). Despite the apparent recognition that dysto-
cia is painful, little is known about the effects of pain 
resulting from difficulty or assistance at calving on 
production or health, or about the effects of NSAID to 
treat dystocia (Laven et al., 2012) and thus more work 
is warranted. In addition, there is a paucity of data 
on approaches to control this pain with medication. 
Insofar as we know, this is the first study to evaluate 
the short-term benefits of NSAID treatment following 
dystocia, despite the relatively common use of NSAID 
by veterinarians (Laven et al., 2012). 
 Consumption of amniotic fluid by the cow was shown 
to provide some analgesic effect from endogenous opi-
oids (Pinheiro Machado et al., 1997). Current recom-
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mended management practices, such as removing the 
calf immediately after birth (National Farm Animal 
Care Council, 2009), and the relatively high incidence 
of dystocia likely result in many cows not being able to 
benefit from the ingestion of amniotic fluid. Therefore, 
some analgesic assistance in the form of an antiinflam-
matory drug may prove to be beneficial to these ani-
mals. The objective of this study was to evaluate the 
effect of meloxicam on behavior, health, and produc-
tion in cows with assisted calving. The hypothesis was 
that the administration of meloxicam following assisted 
calving would improve feed intake and milk production 
and reduce inflammation and pain in dairy cows.
MATERIALS AND METHODS
General Information
This randomized controlled trial involved Holstein 
cows (n = 42) and heifers (n = 61) that experienced 
assisted parturition at the Elora and Ponsonby Dairy 
Research Centers, University of Guelph (Guelph, ON, 
Canada), with enrollment into the study taking place 
between January 2009 and January 2011. Calving dif-
ficulty was scored as follows: 1, an easy pull by one per-
son with no mechanical assistance, or 2, a difficult pull 
with more than one person, with mechanical assistance, 
or a combination of both. Cows that had a fetotomy or 
caesarean section were excluded. Whether the animal 
had retained fetal membranes at 24 h postcalving was 
recorded systematically. Animals with assisted calving 
were blocked into primiparous and multiparous groups, 
and into calving difficulty, and randomly assigned 
within blocks to receive meloxicam [n = 51; 0.50 mg/
kg of BW, Metacam 20 mg/mL solution for injection; 
Boehringer Ingelheim (Canada) Ltd., Burlington, ON, 
Canada] subcutaneously once 25.4 h (±2.9 SD) follow-
ing calving or to be negative controls (n = 52; injection 
of a similar volume of placebo (the medication vehicle 
solution with no active ingredient once 25.0 h ± 2.8 
SD). Personnel administering the treatments, recording 
data, and performing statistical analyses were blinded 
to treatment assignments.
Cows were housed in tie-stalls through the previous 
lactation and late gestation, and heifers were loose 
housed until 9 wk before expected calving when they 
were moved to a tie-stall. All animals were moved to in-
dividual calving pens (7.0 × 3.1 m; straw pack bedding 
in one half and wood shavings over mattress filled with 
rubber crumbs in the other half) 2 d (±1.8 SD) before 
expected calving based on their due date and appear-
ance of early calving signs (e.g., filling of the udder). 
Cows remained in the maternity pen for 2 d (±0.69 SD) 
after parturition before moving to the tie-stall for lacta-
tion. All animals in both barns were fed the same TMR 
twice daily (0730 and 1300 h) for ad libitum intake. 
The diet in the calving pens was composed of 1 kg of 
hay, 1.6 kg of haylage, 6.6 kg of corn silage, 0.80 kg of 
high-moisture corn, and 2 kg of commercial protein and 
mineral supplement for dry cows (DM basis: CP: 14% 
DM, ADF: 23–25% DM, NDF: 35–40% DM, fat: 3.6– 
3.8% DM, and net energy: 1.45 Mcal/kg). The lactation 
diet was composed of 1.5 kg of hay, 6.2 kg of haylage, 
6.2 kg of corn silage, 4.8 kg of high-moisture corn, 
and 5 kg of supplement containing soybeans, vitamin, 
protein, and mineral (DM basis: CP: 17% DM, ADF: 
20–21% DM, NDF: 30–35% DM, fat: 3.6–3.8% DM, 
and NE: 1.62–1.67 Mcal/kg) and formulated to meet 
requirements (NRC, 2001) for a 650-kg cow producing 
35 kg/d of milk at 3.8% fat. Tie-stalls had feed dividers 
between cows so that individual feed intakes could be 
measured.
DMI, Milk, and BW Data
Individual daily feed intakes were recorded from the 
time the cow entered the maternity pen and then in the 
tie-stalls until 14 DIM. Samples of the prepartum diet 
and the early-lactation diet were collected twice weekly 
and frozen at –20°C for later analysis. Intake calcula-
tions were based on the amount fed to the animal, the 
orts recovered, and the DMI analysis of the samples. 
Milk yield was recorded twice daily until 14 DIM. All 
cows were weighed at enrollment in the study (2 d 
before expected calving at movement into the calving 
pen) and at 60 DIM.
Blood Collection and Analysis
Blood samples were obtained by coccygeal venipunc-
ture immediately after calving and 1, 3, 6, 9, and 12 
DIM. The d 1 blood sample was taken at the time of 
treatment administration and all other blood samples 
were taken in the morning, approximately 3 h after 
feeding, allowed to clot for 1 h, and centrifuged at 
7,000 × g (model CL international clinical centrifuge, 
International Equipment Co., Needham, MA) to collect 
the serum. Blood serum was frozen and submitted for 
analysis to the Animal Health Laboratory, University of 
Guelph. Serum was analyzed for BHBA, NEFA, glucose, 
calcium, and haptoglobin. All analyses were conducted 
using a Roche Cobas 6000 c501 automated chemistry 
analyzer (Roche Canada, Laval, QC, Canada). The 
NEFA and BHBA concentrations were determined us-
ing Randox NEFA and Randox BHBA kits (Randox 
Laboratories Canada Ltd., Mississauga, ON, Canada); 
the analytical sensitivity was 0.10 mmol/L for both as-
says. The inter- and intraassay coefficients of variation 
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were 1.0 and 6.3%, respectively, for NEFA, and 0.50 and 
1.6%, respectively, for BHBA. Glucose concentrations 
were measured using the Roche GLUC3 kit (Roche 
Diagnostics, Laval, QC, Canada). The analytical sen-
sitivity of the glucose assay was 0.10 mmol/L, and the 
inter- and intra-assay coefficients of variation were 2.9 
and 2.4% respectively. Calcium concentrations were 
measured with a commercial kit (Roche Diagnostics). 
The analytical sensitivity of the calcium assay was 0.10 
to 5.0 mmol/L, and inter- and intraassay coefficients 
of variation were 2.1 and 3.3%, respectively. Haptoglo-
bin concentrations were measured by determining the 
hemoglobin binding capacity, using a methemoglobin 
reagent made on site (see Skinner et al., 1991; Skinner 
and Roberts, 1994). The analytical sensitivity of the 
haptoglobin assay was 0.03 g/L; inter- and intraassay 
coefficients of variation were 5.9 and 5.3%, respectively.
Health Events
Rectal temperatures for the first 10 d postcalving 
were taken in the morning using a digital rectal ther-
mometer (Digital Fever Thermometer, Omron Health-
care Inc., Vernon Hills, IL). All clinical health events 
and treatments were recorded for each cow enrolled in 
the study up to 60 d postcalving. Diseases of interest 
for their possible confounding effect included the occur-
rence of retained fetal membranes, milk fever, clinical 
mastitis, clinical ketosis [clinical signs include anorexia, 
depression, and positive ketone test in the milk (BHBA 
≥100 μmol/L)] or urine ketone test (“small” or greater 
on Ketostix strips; Geishauser et al., 1998), metritis 
(systemic illness including fever >39.5°C with fetid 
discharge from the vulva; LeBlanc et al., 2002), and 
displaced abomasum. All cows enrolled in the study 
were assessed for the presence of purulent vaginal dis-
charge (PVD; Dubuc et al., 2010) once between d 30 
and 36 postpartum by visual examination of the tail for 
purulent debris and vaginoscopy. A diagnosis of PVD 
was recorded if either of the 2 conditions was present.
Behavior
Feeding and lying behavior measures were collected 
between January 2010 and January 2011 for a subset 
of animals. Daily feeding behaviors for the first 2 d 
following calving were captured for 31 animals from 
continuous video recording using a wide-angle camera 
lens (Panasonic camera WV-CP504 and lens WV-
LZA61/2S, Panasonic Canada Inc., Mississauga, ON, 
Canada) connected to a recording system (GeoVision, 
UVS 1240E2, GeoVision Inc., USAVisionSys, Irvine, 
CA). Each animal’s feeding behavior was analyzed by 
an individual blind to treatment and was defined as 
follows: (1) feeding visit: a visit consisted of the animal 
inserting her head past the head-gate in the manger up 
to her withers until the animal removed her head from 
the head-gate completely; and (2) total feeding time: 
the total amount of time (min) that the animal spent 
with her head though the head-gate up to the with-
ers without being locked up in the head-gate for other 
reasons (e.g., for milking, for treatment, or for blood 
sampling). Total daily lying time and the number of 
transitions from standing to lying (or vice versa) were 
recorded using a 3-axis accelerometer (Hobo Pendant G 
loggers, Hoskin Scientific Ltd., Burnaby, BC, Canada; 
validation of this device can be found in Ledgerwood 
et al., 2010) attached to the right hind leg, on the day 
that each animal (n = 38) entered the maternity pen, 
and recording at 1-min intervals. Lying behavior for the 
first 3 d following calving was analyzed.
Statistical Analysis
Because there were no existing data at the time of 
trial planning to inform expected production effects, 
sample size was estimated based on a combination of 
practicality of achieving the desired number of dystocic 
cows in a reasonable time from our research dairy and 
effects on important production parameters that were 
both detectable and relevant for the industry. Based on 
the year prior to the start of this study, we expected 
that 100 dystocic cows could be enrolled in this study, 
which would take between 12 and 24 mo depending on 
the incidence of dystocia. Data for the sample size cal-
culations (mean ± SD) were based on previous studies 
conducted at the Elora Dairy Research Center. Sample 
size was therefore calculated for treatment groups (n 
= 48 per group) based on detection of a difference of 
2.4 kg of milk production with an SD of 3.6 kg and a 
difference of 0.50 kg of DMI with an SD of 0.75 kg/d for 
the first 14 DIM with 95% confidence and 90% power.
Data were stored in a spreadsheet using Microsoft 
Office Excel (2010, Microsoft Corp., Redmond, WA) 
and all descriptive statistics and analyses were per-
formed with Stata Intercooled 10.1 (StataCorp, College 
Station, TX). Mixed multivariable models were built 
including a random intercept for animals to account 
for multiple measurements being taken from each cow. 
Mixed linear regression models were for the outcomes 
of DMI, milk production, and serum metabolites 
(BHBA, NEFA, glucose, calcium, and haptoglobin). 
Linear regressions were used for the BW differences 
from calving to 60 d postcalving and for feeding be-
havior (visit numbers, total time at the feed bunk, and 
DMI). A logistic regression model was used for the bi-
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nary outcome of presence or absence of PVD. All tests 
were 2-sided and significance was based on α < 0.05. 
For all outcomes, each predictor variable was screened 
individually and offered to the multivariable model if 
P < 0.20. Variables were kept in the final model if P 
< 0.05 if they acted as a confounder or were part of 
a significant interaction term. A confounder variable 
was defined as a nonintervening variable whose inclu-
sion in the model made a 20% or greater change in 
the coefficient of significant variables in the final model 
(Dohoo et al., 2003). Interactions between treatment 
and any significant covariates in the final model were 
tested. Linearity of predictors was assessed using a low-
ess (locally weighted scatterplot smoothing) curve for 
the continuous independent variables. If the linearity 
assumption was violated, the continuous outcome was 
transformed, or a quadratic term was included in the 
model, or the variable was categorized. To account for 
the curvilinear relationship between haptoglobin and 
time, a quadratic term was added to the model. The 
treatment variable was retained in all models, and time 
was forced into all mixed models.
We examined standardized residuals at the observa-
tion level to identify outliers for the linear and mixed 
linear regression models. For identification of outliers in 
the logistic model Pearson and deviance residuals were 
examined. In all random effect models we examined 
BLUPs for any outliers. Normality and homogeneity of 
variance were assessed for the observation-level stan-
dardized residuals for mixed linear models, and BLUPs 
were examined for the cow-level models. A Pearson 
goodness-of-fit test was performed for the regular logis-
tic regression model for the PVD outcome.
RESULTS
BW
The mean (±SD) BW before calving for heifers was 
588 kg ± 19 and for cows was 699 kg ± 21. Treatment 
groups did not differ in BW change from calving to 
60 DIM (β = 2.5 kg; P = 0.80; 95% CI: −17.6, 22.7); 
however, we did observe a decrease in BW at 60 DIM 
compared with calving (β = −34.4 kg; P < 0.001; 95% 
CI: −43.3 to −25.6).
Feed Intake and Milk Production Data
Final regression models for DMI and milk production 
are summarized in Table 1. We observed no differences 
between meloxicam and placebo groups in DMI (overall 
mean ± SD, 12 ± 3 kg/d) or milk production (22 ± 8 
kg/d) over the first 14 DIM (Table 1). Both DMI and 
milk production increased over the first 14 d and heifers 
ate less and produced less milk than multiparous cows 
(Table 1). Animals that had retained fetal membranes 
produced less milk (Table 1) compared with animals 
that expelled their fetal membranes within the first 24 h.
Blood Analysis
The meloxicam and placebo groups did not differ for 
any of the serum metabolites measured. Although we 
found time and parity effects for BHBA and NEFA, 
we found no effect of having retained fetal membranes. 
Cows with retained fetal membranes had higher hap-
toglobin concentrations (β = 0.25 g/L; P < 0.05; 95% 
CI: 0.07, 0.42).
Table 1. Mixed linear regression models of feed DMI from calving to 14 d postpartum and milk production from calving to 14 d postpartum 
for 100 Holstein cows with assisted calving randomly assigned to receive meloxicam (0.5 mg/kg of BW once) or placebo approximately 24 h 
after calving 
Fixed effect Variable
DMI (kg/d) Milk production to 14 DIM (kg/d)
β1 P-value 95% CI β P-value 95% CI
Treatment Meloxicam 0.52 0.30 −1.5, 0.5 −0.35 0.73 −1.7, 2.4
 Placebo Ref.2   Ref.   
Time Day 0.31 <0.001 0.28, 0.34 1.2 <0.001 1.1, 1.3
Parity Heifer −2.0 0.01 −3.4, −0.59 −6.8 <0.001 −9.7, −3.9
 Cow Ref.   Ref.   
 BW at calving (kg) 0.01 0.01 0.00, 0.02 0.03 0.001 0.01, 0.05
RP3 RP — — — −3.9 0.004 −6.5, −1.3
 No RP — — — Ref.   
 Intercept 4.8 — −1.2, 10.9 3.2 — −9.5, 15.8
Random effect Level Variance SE Variance SE
 Cow 6.0 0.19  23.9 0.39  
 Observation 4.0 0.04  25.3 0.11  
1Model coefficient.
2Referent.
3RP = retained fetal membranes; RP covariate was not included in the DMI model because it was not significant.
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Health Events
Rectal temperature (38.8°C ± 0.61 SD) did not differ 
(P = 0.84) over the first 10 DIM between treatment 
groups, and the odds of PVD did not differ between 
treatment groups at 30 to 36 DIM (odds ratio = 1.2; 
P = 0.83).
Lying and Feeding Behavior
Animals in the meloxicam group visited the feed 
bunk more often than those in the placebo group in the 
24 h following treatment (52 ± 56 SD and 28 ± 13 SD, 
respectively; Table 2). Similarly, the total time spent 
feeding for meloxicam-treated animals was greater than 
for animals in the placebo group (223.4 min ± 112.8 SD 
and 156.6 min ± 73.0 SD, respectively; Table 2).
Total daily lying time (666.9 min ± 182.5 SD), num-
ber of lying bouts (14.5 ± 5.2 SD), and average lying 
time per bout (51.2 min ± 21.4 SD) over the first 3 
d postcalving were not different between treatment 
groups (P > 0.05).
DISCUSSION
The administration of meloxicam subcutaneously 
24 h following assisted parturition in Holstein cows 
failed to improve DMI or milk production for the first 
14 DIM. Treatment with NSAIDs has been shown to 
improve DMI in calves following dehorning or after 
developing diarrhea (Heinrich et al., 2010; Todd et al., 
2010). In the study by Heinrich et al. (2010), calves 
treated with meloxicam following cautery dehorning 
had a tendency to consume more feed on d 1 than on d 
0 compared with control calves. In the study by Todd 
et al. (2010), meloxicam-treated calves that developed 
diarrhea and were enrolled after 10 d of age had greater 
odds of consuming all of the offered milk compared 
with placebo-treated calves of the same age with di-
arrhea. Furthermore, calves treated with meloxicam 
began consuming starter ration earlier than placebo-
treated calves (Todd et al., 2010). On the other hand, 
oral meloxicam did not have any effect on DMI when 
given to beef calves that were castrated upon arrival 
at the feedlot compared with steers (Coetzee et al., 
2012). Richards et al. (2009) did not find any effects 
of ketoprofen administration following calving on milk 
yield. Similarly, Duffield et al. (2009) and Shwartz et 
al. (2009) did not find any effect of flunixin meglumine 
on milk yield following calving. We also observed no 
treatment differences in metabolic indicators over the 
first 12 d or in the probability of PVD at 5 wk after 
calving.
The decision to treat at 24 h was made to ensure that 
meloxicam would not interfere with the prostaglandin 
response that may contribute to uterine contractions 
to expel fetal membranes (Horta, 1984). Duffield et 
al. (2009) reported an increase in the odds of having 
retained fetal membranes in animals that received 
flunixin meglumine approximately 2 h after calving. 
Similarly, Waelchli et al. (1999) reported a high proba-
bility of retained fetal membranes in cows administered 
flunixin meglumine following a caesarean section. On 
the other hand, treatment with 2 doses of ketoprofen, 
one immediately following calving and the second 24 h 
later, tended to reduce the incidence of retained fetal 
membranes in dairy cows (Richards et al., 2009). The 
potential for retained fetal membranes using an NSAID 
was the main reason why we waited 24 h before admin-
istering treatment. The NSAIDs act on cyclooxygenase 
enzymes COX-1 and COX-2, which in turn mediate 
prostaglandin production (Lees et al., 2004). Different 
NSAIDs have different affinities for COX-1 and COX-2, 
and the exact mechanism of NSAID on retained fetal 
membranes has not yet been determined. However, the 
24-h delay in treatment administration may explain the 
lack of a treatment effect in the current study. Given 
Table 2. Linear regression models for feeding behaviors and DMI for 24 h after injection controlling for baseline (the period from calving to time 
of treatment) for 31 animals with assisted calving and randomly assigned to receive meloxicam (0.5 mg/kg of BW), or placebo, by subcutaneous 
injection approximately 24 h after calving 
Fixed effect Variable
Number of visits Time at the feed bunk (min) DMI (kg)
β1 P-value 95% CI β P-value 95% CI β P-value 95% CI
Treatment Meloxicam 11.5 0.003 4.4, 18.5 40.3 0.04 2.9, 77.7 0.13 0.83 −1.1, 1.4
 Placebo Ref.2   Ref.   Ref.   
Baseline  0.34 0.02 0.07, 0.62 0.39 0.02 0.07, 0.71 0.57 <0.001 0.32, 0.81
Parity3 Heifer — — — — — — −1.7 0.033 −3.2, −0.14
 Cow — — — — — — Ref.   
Intercept  29.0 — 20.0, 38.0 132.1 — 82.1, 182.2 6.7 — 3.2, 10.2
1Model coefficient.
2Referent.
3Parity covariate was not included in the number of visits and time at feed bunk models because it was not significant.
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that the placental separation process usually takes less 
than 6 h (van Werven et al., 1992), future investiga-
tions should consider administering meloxicam sooner 
(i.e., immediately following calving) to examine the 
risk of retained fetal membranes and ability to mitigate 
pain from calving.
Cows that received meloxicam spent more time at 
the manger on the day after treatment, although DMI 
did not differ in the 24 h after injection. The increased 
number of feeding visits and total time spent feeding 
for the first 24 h after calving in the meloxicam-treated 
animals suggests that administration of this NSAID 
could be alleviating some postcalving pain. Similarly, 
Theurer et al. (2012) reported that meloxicam-treated 
calves spent significantly more time with 1 foot from 
the grain bunk on d 2 and 5 following dehorning 
compared with control calves, suggesting a potential 
positive effect of meloxicam on behavioral changes fol-
lowing a painful procedure. Other work has shown that 
lame cows at pasture grazed for shorter periods and 
had longer lying times than nonlame cows (Hassall et 
al., 1993; Winckler and Brill, 2004). Cows that received 
ketoprofen following left displaced abomasum surgery 
had greater odds of going to the feed bunk at fresh feed 
delivery for the first 3 d postsurgery compared with 
control animals based on observations by producers 
blinded to treatment (Newby et al., 2013). Improved 
DMI in dairy cows should improve milk yield, as intake 
and production are closely related, and potentially re-
duce the risk of disease (Drackley, 1999). Because this 
was not observed in the current study, the potential 
benefits may have been masked by the elevated endor-
phins still in the blood following parturition (Hydbring 
et al., 1999). Perhaps the cows that received meloxicam 
and spent more time at the feed bunk ate smaller but 
more frequent meals. Further research is needed to in-
vestigate the effects of longer term NSAID administra-
tion, or a higher dosage of NSAID, on feeding behavior 
because return to a more normal feeding behavior may 
improve rumen health with smaller and more frequent 
meals (Krause and Oetzel, 2006). The present study 
was done in a noncompetitive environment for the 
cows, where they had access to their own feed bunk. It 
would be interesting to investigate the potential ben-
efits of meloxicam administration following calving on 
the feeding behavior of cows in a freestall system.
In the present study, the lack of effect of meloxicam 
on DMI, milk production, blood parameters, or lying 
behavior following an assisted calving could be due 
to insufficient attenuation of inflammation or pain or 
because the duration of effect of the meloxicam regi-
men used in this study was too short. Conversely, the 
differences in feeding behavior suggest that effects were 
produced and that further investigation of antiinflam-
matory treatment strategies is warranted.
CONCLUSIONS
This is one of the first studies to investigate the ef-
fects of administering the NSAID meloxicam following 
assisted calving. We observed no differences associated 
with treatment in DMI, milk production, or metabolic 
indicators. These outcomes may not have been sensitive 
to the effect of the drug or the dose regimen used in 
this study. We did observe short-term effects on feeding 
behavior that merit further investigation. We recom-
mend future research to investigate different analge-
sic strategies (different dose, timing, and duration of 
meloxicam, and different drugs) to mitigate the effects 
of assisted calving.
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